Literature DB >> 20932460

Extracellular production of recombinant proteins using bacterial autotransporters.

Wouter S P Jong1, Ana Saurí, Joen Luirink.   

Abstract

Escherichia coli is still a very popular host for the production of recombinant proteins at an analytical or industrial scale. Secretion of the proteins into the culture medium or display at the cell surface would be preferred in many applications but is hampered by the complex two-layered cell envelope. The autotransporter pathway is used by E. coli to secrete virulence factors via a relatively simple but efficient and specific mechanism. Here we discuss recent progress in the structural and mechanistic analysis of this pathway and the implications for future development of a versatile platform for secretion and display of heterologous proteins.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20932460     DOI: 10.1016/j.copbio.2010.07.009

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  22 in total

1.  Autotransporter-based antigen display in bacterial ghosts.

Authors:  Anna Hjelm; Bill Söderström; David Vikström; Wouter S P Jong; Joen Luirink; Jan-Willem de Gier
Journal:  Appl Environ Microbiol       Date:  2014-11-14       Impact factor: 4.792

2.  Stepwise folding of an autotransporter passenger domain is not essential for its secretion.

Authors:  Wanyoike Kang'ethe; Harris D Bernstein
Journal:  J Biol Chem       Date:  2013-10-28       Impact factor: 5.157

3.  Multiple driving forces required for efficient secretion of autotransporter virulence proteins.

Authors:  Igor Drobnak; Esther Braselmann; Patricia L Clark
Journal:  J Biol Chem       Date:  2015-02-10       Impact factor: 5.157

Review 4.  Of linkers and autochaperones: an unambiguous nomenclature to identify common and uncommon themes for autotransporter secretion.

Authors:  Igor Drobnak; Esther Braselmann; Julie L Chaney; Denisse L Leyton; Harris D Bernstein; Trevor Lithgow; Joen Luirink; James P Nataro; Patricia L Clark
Journal:  Mol Microbiol       Date:  2014-11-24       Impact factor: 3.501

5.  Site-saturation mutagenesis of mutant L-asparaginase II signal peptide hydrophobic region for improved excretion of cyclodextrin glucanotransferase.

Authors:  Abbas Ismail; Rosli Md Illias
Journal:  J Ind Microbiol Biotechnol       Date:  2017-09-18       Impact factor: 3.346

Review 6.  The structural biology of β-barrel membrane proteins: a summary of recent reports.

Authors:  James W Fairman; Nicholas Noinaj; Susan K Buchanan
Journal:  Curr Opin Struct Biol       Date:  2011-06-28       Impact factor: 6.809

Review 7.  Increasing recombinant protein production in Escherichia coli through metabolic and genetic engineering.

Authors:  Hendrik Waegeman; Wim Soetaert
Journal:  J Ind Microbiol Biotechnol       Date:  2011-09-08       Impact factor: 3.346

Review 8.  Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.

Authors:  Chung-Jr Huang; Henry Lin; Xiaoming Yang
Journal:  J Ind Microbiol Biotechnol       Date:  2012-01-18       Impact factor: 3.346

9.  Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach.

Authors:  Maria H Daleke-Schermerhorn; Tristan Felix; Zora Soprova; Corinne M Ten Hagen-Jongman; David Vikström; Laleh Majlessi; Joep Beskers; Frank Follmann; Karin de Punder; Nicole N van der Wel; Thomas Baumgarten; Thang V Pham; Sander R Piersma; Connie R Jiménez; Peter van Ulsen; Jan-Willem de Gier; Claude Leclerc; Wouter S P Jong; Joen Luirink
Journal:  Appl Environ Microbiol       Date:  2014-07-18       Impact factor: 4.792

10.  Eeyarestatin 24 impairs SecYEG-dependent protein trafficking and inhibits growth of clinically relevant pathogens.

Authors:  Maurice Steenhuis; Gregory M Koningstein; Julia Oswald; Tillman Pick; Sarah O'Keefe; Hans-Georg Koch; Adolfo Cavalié; Roger C Whitehead; Eileithyia Swanton; Stephen High; Joen Luirink
Journal:  Mol Microbiol       Date:  2020-09-03       Impact factor: 3.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.